Growth Metrics

Biodesix (BDSX) Gross Profit (2019 - 2026)

Biodesix filings provide 8 years of Gross Profit readings, the most recent being $21.3 million for Q1 2026.

  • On a quarterly basis, Gross Profit rose 49.77% to $21.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $81.8 million, a 23.25% increase, with the full-year FY2025 number at $80.9 million, up 26.96% from a year prior.
  • Gross Profit hit $21.3 million in Q1 2026 for Biodesix, down from $26.8 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $26.8 million in Q4 2025 to a low of $3.3 million in Q1 2022.
  • Median Gross Profit over the past 5 years was $12.7 million (2024), compared with a mean of $13.0 million.
  • Biggest five-year swings in Gross Profit: tumbled 68.89% in 2022 and later soared 115.2% in 2024.
  • Biodesix's Gross Profit stood at $6.3 million in 2022, then soared by 79.24% to $11.3 million in 2023, then surged by 113.26% to $24.1 million in 2024, then rose by 11.24% to $26.8 million in 2025, then decreased by 20.32% to $21.3 million in 2026.
  • The last three reported values for Gross Profit were $21.3 million (Q1 2026), $26.8 million (Q4 2025), and $17.7 million (Q3 2025) per Business Quant data.